May 1, 2026 Log in

News

[Pao Feng Biotechnology] May 2026 Revenue Reaches NT$234 Million (YoY +1.8%)

Citation-Grade Primary-source linked Schema.org verified NQ 33 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published May 1, 2026 9:00 AM ・ Updated Jun 13, 2026 11:56 PM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

Pao Feng Biotechnology (1760) announced its revenue for May 2026, reaching NT$234 million (234,475 thousand NTD), representing a modest year-on-year increase of 1.8%.

Pao Feng Biotechnology (1760) announced its revenue for May 2026, reaching NT$234 million (234,475 thousand NTD), representing a modest year-on-year increase of 1.8%.

PRIMARY SOURCE Original source: https://openapi.twse.com.tw/revenue/twse-rev-1760-11505 Distributor: PR Times
Published: May 1, 2026

Company Code: 1760 Company Name: Pao Feng Biotechnology Industry: Biotechnology and Medical Care Data Period: 2026-05 Monthly Revenue: 234,475 thousand NTD (234 million NTD) Year-on-Year Change: +1.8%

Keywords: Monthly Revenue, Biotechnology and Medical Care

FACT BOX

Source: PR Times
Category: News
Dates in source: 2026-05

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　May 1, 2026 9:00 AM — Distributor PR Times
Collected　Jun 12, 2026 8:00 AM
AI structured & analyzed　Jun 12, 2026 4:44 PM
Desk-reviewed & published　May 1, 2026 9:00 AM

FAQ

What is Pao Feng Biotechnology's revenue for May 2026?

The monthly revenue is NT$234,475 thousand (approximately NT$234 million).

How did the revenue change compared to last year?

It increased by 1.8% compared to the same month last year.

What is the company code and industry of Pao Feng?

The company code is 1760, and the industry is Biotechnology and Medical Care.

Cite this article — HOW TO CITE

Washin AI News Desk“[Pao Feng Biotechnology] May 2026 Revenue Reaches NT$234 Million (YoY +1.8%)”AI News by Washin Village（和心村）, May 1, 2026. https://aeo.idaeo.ai/ai/%E5%AF%B6%E9%BD%A1%E5%AF%8C%E9%8C%A6/en/news/2026-05-01-%E5%AF%B6%E9%BD%A1%E5%AF%8C%E9%8C%A6-2026-05-%E6%9C%88%E7%87%9F%E6%94%B6-2-34%E5%84%84-%E5%B9%B4%E5%A2%9E-1-8

AI CRAWLER ACTIVITY

as of Aug 20, 2026

AI crawler visits to this article (cumulative)Measuring since publication (no visits recorded yet)

Site-wide cumulative

Applebot

bot_visits_summary

2313k

last Aug 20, 2026

GPTBot

bot_visits_summary

1895k

last Aug 20, 2026

ClaudeBot

bot_visits_summary

1341k

last Aug 20, 2026

Amazonbot

bot_visits_summary

681k

last Aug 20, 2026

Bingbot

bot_visits_summary

516k

last Aug 20, 2026

Meta AI

bot_visits_summary

322k

last Aug 20, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 寶齡富錦 Back to newsroom (77)

Copied